News | March 05, 2014

Study Shows Gamma Knife Helps Patients with Trigeminal Neuralgia

Radiation Therapy Gamma Knife Stereotactic Radiosurgery

March 5, 2014 — Research by Beaumont Health System radiation oncologists and neurosurgeons found that symptoms of trigeminal neuralgia (TN) were reduced in those treated with Gamma Knife stereotactic radiosurgery. The results were published in the February issue of the journal Clinical Neurology and Neurosurgery.

TN is a disorder of the trigeminal nerve, which is responsible for feeling in the face. In most cases, the facial pain is caused by a blood vessel pressing on the nerve. It is believed that TN is caused by deterioration of the protective covering of the trigeminal nerve.

"The Gamma Knife is not actually a knife," says Inga Grills, M.D., radiation oncologist, Beaumont Hospital, Royal Oak and associate professor, Oakland University William Beaumont School of Medicine. "Gamma Knife stereotactic radiosurgery is a nonsurgical technique that precisely delivers a high dose of radiation to a targeted area. It sends more than 200 beams of gamma radiation, while the low intensity of the individual beams avoids causing damage to the surrounding tissues."

Principal investigator Grills and a team of Beaumont researchers analyzed data of 149 patients who were treated with Gamma Knife Stereotactic Radiosurgery (GK SRS). Following the treatment, patients were evaluated at about two weeks, then every three to six months. Patients reported if they experienced normal, decreased or no facial pain. Researchers concluded GK SRS provides acceptable relief for those with TN, especially those who are not suitable or have failed medical or surgical treatments.

"This study demonstrates patients with severe facial pain caused by trigeminal neuralgia will experience less discomfort after Gamma Knife Stereotactic Radiosurgery,” Grills said. “They can resume daily activities such as brushing their teeth, washing their face and even smiling, without the unbearable sensation that is often caused by this condition.”

Approximately 150,000 people are diagnosed with TN every year, according to the American Association of Neurological Surgeons. Women over the age of 50 are among those who are most commonly diagnosed. Those at risk are people with high-blood pressure or with multiple sclerosis.

For more information: http://www.journals.elsevier.com/clinical-neurology-and-neurosurgery

Related Content

DOSIsoft Receives FDA 510(k) Clearance for Planet Onco Dose Software
Technology | Information Technology | June 20, 2019
DOSIsoft announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market Planet...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...
Black Men Less Likely to Adopt Active Surveillance for Low-Risk Prostate Cancer
News | Prostate Cancer | June 17, 2019
A new study reveals black men are less likely than white men to adopt an active surveillance strategy for their...
University Medical Center Groningen Performs First Automatic Log-based Proton Therapy Patient QA
News | Proton Therapy | June 14, 2019
IBA announced the physics team of University Medical Center Groningen (UMCG) in the Netherlands has developed and...
ASTRO Applauds New Prior Authorization Legislation
News | Radiation Therapy | June 07, 2019
The American Society for Radiation Oncology (ASTRO) released a statement applauding Congress’s introduction of...
IBA Dosimetry Launches myQA iON
News | Quality Assurance (QA) | June 07, 2019
IBA (Ion Beam Applications S.A.) announced the launch of myQA iON at the 2019 Particle Therapy Co-Operative Group (...
Study Identifies MRI-Guided Radiation Therapy as Growing Market Segment
News | Image Guided Radiation Therapy (IGRT) | June 06, 2019
Revenues from the magnetic resonance imaging (MRI)-guided radiation therapy systems market exceeded $220 million in...
RefleXion Opens New Manufacturing Facility for Biology-guided Radiotherapy Platform
News | Radiation Therapy | May 31, 2019
RefleXion Medical recently announced the opening of its new manufacturing facility at its headquarters in Hayward,...
Accuray Radixact

Accuray Radixact

Feature | Radiation Therapy | May 29, 2019 | By Jeff Zagoudis
While radiation therapy as a disciplin
Sponsored Content | Case Study | Radiation Therapy | May 29, 2019
The so-called “Grey Tsunami” of baby boomers using healthcare services isn’t taking the Radiation Medicine Program at